Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil Augmentation of Memory Training in Older Adults
NCT02988908Phase 4Completed
- Sponsor
- Stanford University
- Start
- Apr 2000
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Memory impairment comparing Drug: Donepezil with Placebo (Control) (2 arms). Primary endpoints: Change in recall of Word List over time at 52 weeks and Change in recall of Name-Face pairs over time at 52 weeks. Started Apr 2000; status: completed.
02
Drugs
donepezil
03
Conditions
Memory impairment
Beyond the preview
Go deeper on NCT02988908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02988908.